High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas.

Takenaka, K; Shinagawa, K; Maeda, Y; Makita, M; Kozuka, T; Ashiba, A; Yamamoto, K; Fujii, N; Nawa, Y; Hiramatsu, Y; Sunami, K; Ishimaru, F; Yoshimo, T; Kiura, K; Harada, M

Takenaka, K; Shinagawa, K; Maeda, Y; Makita, M; Kozuka, T; Ashiba, A; Yamamoto, K; Fujii, N; Nawa, Y; Hiramatsu, Y; Sunami, K; Ishimaru, F; Yoshimo, T; Kiura, K; Harada, M.

Affiliation

Takenaka K; Second Department of Internal Medicine, Okayama University Medical School, Japan. ktakenaka@clubaa.com

Leuk Lymphoma ; 42(6): 1297-303, 2001.

Article in En | MEDLINE | ID: mdl-11911411

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; CD56 Antigen/analysis; Hematopoietic Stem Cell Transplantation; Lymphoma, T-Cell/therapy; Nose Neoplasms/therapy; Adolescent; Adult; Aged; Combined Modality Therapy; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell/mortality; Male; Middle Aged; Nose Neoplasms/mortality; Salvage Therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Nose Neoplasms / Lymphoma, T-Cell / Hematopoietic Stem Cell Transplantation / CD56 Antigen Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links